ORDRCC

  • Welcome
  • Leadership
  • Administrative Core
  • Cores
    • Clinical Characterization and Biorepository Core
    • Human Phenotyping Core
    • Request Services
  • Investigator Support
    • Center Investigators
    • Proposal Development
    • Pilot Funding
  • For Patients
    • Get Involved
    • Getting to the Clinic
  • Discoveries
  • shutterstock_211939057

    What we're about



    Advancing prediction, prevention, and precision therapy for patients with rheumatic diseases
  • shutterstock_347560208

    Who we are



    Over 200 researchers spanning the basic, clinical, and analytical sciences
  • b2jyXojmp3qjCvjQxTK50QRmNNc2VNzkte8d3Oq2JOoRTKHVnmKyhHJawEB5A_QVtWgYzBFMgTvdcIe20Mtw0Q-1024×681

    How we help



    World-class core facilities and investigator support to drive groundbreaking research and launch distinctive careers
  • DrMerrill_patientstudiesphoto-1024×569

    Why we care



    Patients with rheumatic diseases need better tests and personalized treatments so they can live healthier, longer lives

Extensive Cohort Collections

Our CAP-accredited biorepository manages some of the largest existing collections of SLE, Sjogren’s, RA, and osteoarthritis samples

Cutting Edge Methodologies

The Human Phenotyping Core offers single-cell technologies, including CyTOF, Spatial Transcriptomics, and scRNASeq

Clinical Research Expertise

A physician examines a patient's hand in an exam room
The Clinical Core assists with IRB approvals, study recruitment, and clinical research visits

RSS Recent Publications

  • Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity November 28, 2025
  • Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment October 6, 2025
  • Evaluating Anti-CCL25 as a Therapeutic Strategy to Disrupt Foci Formation in a Spontaneous Murine Model of Sjögren's Disease September 27, 2025
  • A Randomized, Placebo-Controlled Trial of Hydroxychloroquine in Incomplete Lupus September 16, 2025
  • Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland May 30, 2025
  • A cross-sectional observational study of patients with sicca with salivary autoantibodies defines a potential new phenotype of Sjögren's disease May 4, 2025
  • Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis March 17, 2025

Cite ORDRCC Support
Publications that used ORDRCC consultations, services, or resources should cite P30AR073750.

Oklahoma Rheumatic Disease Research Cores Center

At the Oklahoma Medical Research Foundation in Oklahoma City, OK

Copyright © 2026 OKLAHOMA MEDICAL RESEARCH FOUNDATION · Log in

MENU
  • Welcome
  • Leadership
  • Administrative Core
  • Cores
    • Clinical Characterization and Biorepository Core
    • Human Phenotyping Core
    • Request Services
  • Investigator Support
    • Center Investigators
    • Proposal Development
    • Pilot Funding
  • For Patients
    • Get Involved
    • Getting to the Clinic
  • Discoveries